Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenue $ 0 $ 0
Costs and Operating Expenses    
Cost of revenue, excluding depreciation 0 0
Research and development expenses, excluding depreciation 299,218 246,245
Selling, general and administrative expenses, excluding depreciation 196,029 194,736
Depreciation 11,554 8,921
Total costs and operating expenses 506,801 449,902
Loss from operations (506,801) (449,902)
Other income (expense)    
Interest (expense) income (2,249) 103
Gain on fair value change in contingent earnout shares liability 26,044 104,446
Loss on fair value change in private placement warrants liability 0 (1,639)
Loss on extinguishment of debt (4,626) 0
Other (expense) income, net (62) 224
Loss before income taxes (487,694) (346,768)
Provision for income taxes 0 0
Net loss and comprehensive loss (487,694) (346,768)
Net loss and comprehensive loss $ (487,694) $ (346,768)
Net loss per share, basic (in dollars per share) $ (1.81) $ (1.52)
Net loss per share, diluted (in dollars per share) $ (1.81) $ (1.52)
Weighted-average shares outstanding, basic (in shares) 269,768 227,909
Weighted-average shares outstanding, diluted (in shares) 269,768 227,909